-- 味之素(東京證券交易所代號:2802)2025財年歸屬於母公司股東的淨利飆升92%,達到1,347億日圓,上年同期為703億日圓。 這家食品調味料製造商週四向東京證券交易所提交的文件顯示,其每股收益從去年同期的69.77日圓增至138.36日圓。 截至3月31日的財年,銷售額成長3.5%,達到1.584兆日元,而上年同期為1.531兆日圓。 該公司宣布派發末期股息,每股24日元,將於6月22日起支付。 該公司預計2026財年歸屬於股東的淨利為1,200億日元,基本每股收益為126.16日元,銷售額為1.723兆日元。 味之素計畫派發年度中期股息和年終股息,每股25日元,高於去年同期派發的股息數。
Related Articles
Indian Equities End Flat on Thursday as Earnings Support Offsets Weakness
Indian benchmark indices ended largely unchanged on Thursday as gains driven by earnings-related buying offset broader market weakness.The BSE Sensex fell 114.00 points, or 0.2%, to close at 77,844.52, while the NSE Nifty 50 slipped 4.30 points, or 0.02%, to settle at 24,326.65.Expectations of easing tensions between the US and Iran further supported investor sentiment. Tehran is reportedly reviewing the latest U.S. proposals aimed at ending the conflict.In corporate developments, Bharat Forge (NSE:BHARATFORG, BOM:500493) reported a decline in consolidated profit in fiscal Q4 to 2.33 billion rupees from 2.83 billion rupees a year earlier. Revenue from operations, however, rose to 20.3 billion rupees from 17.0 billion rupees.Larsen & Toubro (NSE:LT, BOM:500510) gained after its buildings and factories business secured three large orders from a real estate client for projects across three states, according to a filing. The company classifies large orders in the range of 25 billion rupees to 50 billion rupees.
Heilongjiang ZBD Pharmaceutical Wins Bids for Traditional Chinese Drug Program
Two of Heilongjiang ZBD Pharmaceutical's (SHA:603567) products won bids from China's procurement program for traditional medicines, according to a Thursday filing with the Shanghai bourse.The products include ZBD's quick-acting sugar syrup for children, indicated for fever and sore throat, and its Xiangdan injection for angina pectoris or chest pain, the filing said.
BTIG Upgrades Fortinet to Buy From Neutral, Price Target is $125
Fortinet (FTNT) has an average rating of hold and mean price target of $102.03, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)